There is no such thing as acquiring delcath cheap. Revenue is so iffy and probably 2025 would be the likely year for ICC approval, which is still no guarantee on either approval or commercial firepower.
Those are the facts to the chemosat story. Unless there is indeed interest, this is a phase 3 story and more tidbits will come in 2nd half of 2018 assuming survival via financing
News 
Market Data 
Discover 
